From: The market trend analysis and prospects of scaffolds for stem cells
Company | Primary supplier | Secondary supplier | % of all selections | Total no. of selections |
---|---|---|---|---|
3D Biomatrix | 0% | 3% | 2% | 2 |
3D Biotek | 1% | 6% | 4% | 5 |
BD Biosciences | 41% | 11% | 27% | 35 |
Bellbrook Labs | 0% | 2% | 1% | 1 |
CellASIC | 3% | 0% | 2% | 2 |
CELLnTEC | 1% | 3% | 2% | 3 |
Corning | 9% | 14% | 11% | 15 |
Electrospinning Company | 0% | 0% | 0% | 0 |
EMD-Millipore | 3% | 2% | 2% | 3 |
Global Cell Solutions | 4% | 2% | 3% | 4 |
GlycosanBiosystems | 0% | 2% | 1% | 1 |
Hamilton Company | 0% | 2% | 1% | 1 |
Insphero | 4% | 3% | 4% | 5 |
InvivoSciences | 0% | 2% | 1% | 1 |
Kuraray | 0% | 0% | 0% | 0 |
Life Technologies (Invitrogen) | 16% | 16% | 16% | 21 |
Lonza | 3% | 10% | 6% | 8 |
MatTek | 3% | 2% | 2% | 3 |
Microtissues | 0% | 0% | 0% | 0 |
OrganDot 3D | 0% | 0% | 0% | 0 |
QGel Bio | 0% | 0% | 0% | 0 |
RealBio Technology | 0% | 0% | 0% | 0 |
RegeneMed | 1% | 1% | 1% | 1 |
Reinnervate | 1% | 2% | 2% | 3 |
Scivax | 3% | 2% | 2% | 2 |
Sigma-Aldrich | 4% | 8% | 8% | 11 |
Synthecon | 1% | 2% | 2% | 2 |
TAP Biosystems | 0% | 1% | 1% | 1 |
Tissue Growth Technologies | 0% | 0% | 0% | 0 |
ThermoScientific | 0% | 2% | 2% | 2 |
Zyoxel | 0% | 0% | 0% | 0 |
Total | 69 | 63 | 132 | 132 |